Drugs / G-CSF
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00185692 Background | Aug 2000 → Dec 2010 | B-cell chronic lymphocytic leukemia, Hodgkins lymphoma, cancer, graft versus host disease +1 | Stanford University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | G-CSF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00185692 ↗ |
| Route | Subcutaneous | “16 mg/kg, SQ” NCT00185692 ↗ |